Discontinued — last reported Q4 '25
Financing
Share Buybacks
Roivant Sciences Share Buybacks decreased by 29.5% to $208.29M in Q2 2025 compared to the prior quarter. Year-over-year, this metric declined by 67.9%, from $648.39M to $208.29M.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2014
Last reportedQ4 2025
How to read this metric
High repurchases often signal management's confidence in the company's valuation or a strategy to improve earnings per share.
Detailed definition
The cash outflow associated with the company buying back its own shares from the open market. This is a primary method f...
Peer comparison
Common among mature, cash-generative companies; peers in the healthcare sector often balance this with R&D investment.
Metric ID:
share_repurchasesHistorical Data
15 periods
| Q2 '21 | Q3 '21 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $2.25M | $8.33M | -$8.33M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $648.39M | $106.05M | $243.35M | $295.45M | $208.29M |
| QoQ Change | — | — | +270.7% | -200.0% | +100.0% | — | — | — | — | — | — | -83.6% | +129.5% | +21.4% | -29.5% |
| YoY Change | — | — | — | -470.7% | — | — | -100.0% | +100.0% | — | — | — | — | — | — | -67.9% |
Range-$8.33M – $648.39M
Avg YoY Growth-134.6%
Median YoY Growth-83.9%
Share Buybacks at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's share buybacks?
- Roivant Sciences (ROIV) reported share buybacks of $208.29M in Q2 2025.
- How has Roivant Sciences's share buybacks changed year-over-year?
- Roivant Sciences's share buybacks decreased by 67.9% year-over-year, from $648.39M to $208.29M.
- What does share buybacks mean?
- Cash spent by the company to buy back its own stock.